Join Telegram
LIVE23 Nov 2026, 02:35 AM IST
Home / IPO / Aptus Pharma
LISTEDSMEPharmaceuticalsIncorporated2010Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations

Aptus Pharma IPO

Open 23rd Sep 2025 · Close 25th Sep 2025 · Listing 30th Sep 2025

Verified 2026-10-0894% data coverage
Issue Price₹70.00
Listing Price₹80.80
Current Price—
Listing Gain15.43%
Current Return—

At a glance

Updated 2026-10-08

The shares listed at ₹80.80, a 15.43% move from the issue price. Aptus Pharma is a SME IPO with an issue size of ₹13.02 crore, proposed for listing on BSE SME. The offer opens on 23rd Sep 2025 and closes on 25th Sep 2025. The issue structure includes a fresh issue of ₹12.36 crore. The current listing schedule points to 30th Sep 2025.

Issue details

Listing atBSE SME
Issue typeBook Build Issue
Issue size₹13.02 Cr
Fresh issue₹12.36 Cr
Face value₹10
Price band₹65.00–₹70.00
Allotment26th Sep 2025
Listing30th Sep 2025

Listing performance

Full performance ↗
Issue price₹70.00
Listing price₹80.80
Current price—
Listing gain15.43%
Current return—
Price progressionIssue → Listing → Current

Grey market

GMP page ↗
Latest GMP₹4.00
GMP / upper price5.71%
Est. listing₹74.00
GMP is unofficial sentiment data, not an exchange price.

Timeline

Opens23rd Sep 2025
Closes25th Sep 2025
Allotment26th Sep 2025
Refund29th Sep 2025
Demat29th Sep 2025
Listing30th Sep 2025

Subscription demand

Full bidding ↗
Total22.27×

Lot size

InvestorLotsSharesAmount
Minimum Bid14000₹280,000

Company

Incorporated2010

Use of proceeds

ObjectAmount
Capital Expenditure for Office Premises with furniture and Industrial Racks₹1.63 Cr
Working Capital₹8.00 Cr
General Corporate Purposes₹1.91 Cr
Issue Expenses₹1.48 Cr
Total₹13.02 Cr

Financial performance

Year-wise operating scale, profitability and balance-sheet context.
Full financials ↗
Revenue24.64₹ Cr · +37.8% vs prior year
EBITDA4.76₹ Cr · +219.5% vs prior year
PAT3.10₹ Cr · +287.5% vs prior year
Assets21.92₹ Cr · +118.5% vs prior year
Net Worth6.97₹ Cr · +293.8% vs prior year
Borrowing10.36₹ Cr · +95.1% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore
Year comparisonCompare scale and profitability at a glance
₹ crore

31 Mar 2023

Assets6.22
Total Income13.90
EBITDA0.57
Profit After Tax0.19
NET Worth0.97
Reserves and Surplus0.67
Total Borrowing2.21

31 Mar 2024

Assets10.03
Total Income17.88
EBITDA1.49
Profit After Tax0.80
NET Worth1.77
Reserves and Surplus1.47
Total Borrowing5.31

31 Mar 2025

Assets21.92
Total Income24.64
EBITDA4.76
Profit After Tax3.10
NET Worth6.97
Reserves and Surplus1.97
Total Borrowing10.36

KPIs

KPIMar 31, 2025
ROE44.50%
ROCE45.66%
Debt / Equity1.49%
RoNW44.50%
PAT Margin12.62%
EBITDA Margin19.31%

Valuation & shareholding

Pre-IPO EPS6.20
Post-IPO EPS4.52
Pre-IPO P/E11.29
Post-IPO P/E15.49
Promoter holding pre100%
Promoter holding post72.89%
Market cap₹48.02 Cr.

Peer comparison

CompanyEPSP/ERoNWNAV
Aptus Pharma IPO—15.49 x——
Himalaya Nutravedics IPO—12.63 x——
Bio Medica IPO—13.45 x——
Goldline Pharmaceutical IPO—14.56 x——

Issue expenses

ExpenseAmount
Capital Expenditure for Office Premises with furniture and Industrial Racks₹1.63 Cr
Working Capital₹8.00 Cr
General Corporate Purposes₹1.91 Cr
Issue Expenses₹1.48 Cr
Total₹13.02 Cr

Registrar & lead managers

Registrar

Bigshare Services Pvt.Ltd.

Lead managers

  • Interactive Financial Services Ltd.

Offer documents

Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-10-08.
IPO UPDATE ALERTS

Track Aptus Pharma without missing an update

Register for subscription, GMP, allotment and listing notifications.

Register for IPO Updates →